RE: Fundamental analysis difficultiesI believe this company has an extremely narrow road to follow in the next few quarters. As its costs are up by roughly the same amount that its revenue has grown, so it just kind of cancel each other out. There it sits at the same position as before, if not worse. The recent fund given to the company is quite a small amount as r&d goes, it would be quickly burned out. Although it seems to be standing in the first stages of growth for a company cycle, it remains not to do anything particularly interesting. Unless they come out with a particularly amazing product soon, they will have to result to stock dilution or a more financial burden as in debt.